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谢水平。通过研究, 我们认为 ProT α能够明显促进胰岛分泌胰岛素。此外，对
于由链脲佐菌素（STZ）诱导的 1 型糖尿病小鼠，ProT α 能够明显降低其空腹






在胰岛β细胞的胞浆中；然而，当胰岛与 ProT α经过一段时间的孵育，ProT α
将由β细胞的胞浆转移到细胞核中。所以，我们认为 ProTα 对胰岛β细胞具有
重要的作用：首先，我们证实了 ProT α是β细胞的重要组成成分之一，其功能



























































High sucrose and high fat diet (HSFC diet) is more and more popular 
in the world. There are a lot of evidence indicated that a long term intake 
HSFC diet will lead overweight obesis that usually will cause glucose 
intolerant,insulin resistance and eventually result in type 2 diabetes. 
Even worse, diabetes will cause ketoacidosis, cerebrovascular disease, 
diabetic nephropathy and other syndromes. How to prevent and cure them 
also has been paid more medical attention. Diabetes is Characterized by 
the damnification of pancreatic β cell cellularity and function, which 
results in insulin insufficiency. Insulin treatment in vitro is 
considered to be the main treatment of disease. However, β cell 
regeneration and anti apoptosis will become a new approach for treating 
diabetes patients.  
The important biological function of Prothymosin α(ProTα) have been 
reported to promote immunity, cell proliferation and anti-oxidation. 
Because of the special amino acid sequence,the steady and stronge acidic 
protein ProTα can be resolved in vivo by enzyme action with the result 
of thymosins α1 and thymosinsα11. That's why we try to study the effects 
and mechanisms of oral ProTα on glucose and lipid metabolism.  
After we fed mice with HSFC diet for 60 days, the physiological and 
histological results showed that ProTα could obviously enhance glucose 
intolerant ability, reduce fat accumulation, prevente over weight, 
decrease triglyceride level in serum and fat index in body, protect liver 
and pancreatic tissue from the damage of HSFC. These remarkable results 
indicated that ProTα can regulate the glucose and lipid metablism, 
maintain the normal metablism level. Then we propose that ProTα can 
obviously promote pancreatic islets to secrete insulin. Moreover, ProTα 
could obviously reduce the fasting blood glucose of mice that were induced 














type 1 diabetes mellitus (T1DM) by streptozotocin（STZ）. According to 
the reported mechanisms of STZ-induced T1DM, we consider that ProTα can 
protect pancreatic β cell and promote insulin release by enhancing the 
proliferation, anti-apoptosis ane anti-oxidation of β cell.  
After the preparation of polyclonal antibody to ProTα, we gained many 
pancreatic islets to analyse the expression of ProTα in β cell with 
immunity method, including cell immunofluorescence, immunity 
histo-chemistry and western-blotting analysis. We found that ProTα was 
expressed in β cell. It was located in cytoplasm of βcell in normal 
condition. However, when the islets were incubated with ProTα, the ProTα 
was transported into nucleus of β cell. So we hypothesize that ProTα 
has important function on pancreatic β cell. Firstly, ProTα is an 
important content in β cell. It will affect β cell to regulate insulin 
release. Secondary, ProTα may play an important role in proliferation 
and anti apoptosis of β cell, especilly when ProTα transport into 
nucleus of  β cell, it might have relationship to β cell proliferation 
and anti-apoptosis. Furthermore, there might be another mechanism that 
ProTα can protect β cell from damage factors such as nitric oxide and 
superoxide dismutase by promoting the anti-oxidation of pancreatic β 
cell. 
Our work revealed another new function of ProTα.And the experimental 
results will benefit to find a new method to prevent glucose and lipid 
metablic disturbance. 
 






























计，20 世纪 90 年代，全球共有糖尿病患者约 1.00 亿人；2007 年，全球糖尿病
患者约 2.46 亿人，其中 46%为 40-49 岁的劳动力人口；若不采取任何措施，预
计到 2025 年，全世界糖尿病患者将增加到 3.8 亿人，其中 80%集中在中低收入
国家。2006 年 12 月 20 日，在美国纽约召开的联合国大会通过了划时代的决议，
各国政府首次认识到糖尿病如同艾滋病、结核、疟疾等传染病一样严重威胁着人




示，1980 年患病率为 0.6%，1994 年为 2.5%，1996 年为 3.2%，2002 年为 2.6%。
近年来，随着我国生活水平的提高，糖尿病患者的人数也急剧增加，并且逐步向
青年和青少年蔓延。2007 年世界糖尿病联盟预计我国到 2025 年，糖尿病患者至
少有 4600 万人。2008 年，中华医学会糖尿病分会关于糖尿病流行病学的研究指










































































下，激活了 IKK 酶活性，IKK 酶分别磷酸化 IκBα的 32 和 36-Ser,这一结果导
致平时抑制 NF-κB 的 IκBα泛素化而解除对 NF-κB 的抑制，之后 NF-κB 进入
细胞核，调节目的基因的转录，其中包括一氧化氮合酶（Inducible nitric oxide 




表达将与 FasL 结合引起细胞死亡。体内外实验证明，应用 NF-κB 或者 iNOS 抑
制物可以延迟或者防止糖尿病的发展。细胞因子对胰岛β细胞的影响还通过另一
























物的血浆中含有高水平的游离脂肪酸（Free fat acid, FFA）和甘油三酯。据













第一章  前言 
Zhou YP 等人的体外研究发现，FFA 开始与胰岛细胞作用时，能促进胰岛很快分
泌大量胰岛素；但是当延长作用时间后，则会导致胰岛细胞的葡萄糖诱导胰岛素
分泌（Glucose induce insulin secrete，GIIS）能力下降
[17]
。Umut Ozcan 等
人则通过体内实验证明了 FFA 可诱导 iNOS 上调，结果造成由 NO 诱导的胰岛细胞















































































比较清楚的一个证据是 CDK4 and cyclin D2 在成体胰岛β细胞增殖中起到关键
作用。至少在小鼠中发现，这两个成分在胰岛β细胞增殖中，尤其是在细胞分裂
的 G1/S 期活性增强了。Georgia S 等采用转基因小鼠，通过基因高表达和基因




  相反，抑制细胞分裂周期激酶的抑制物如 P27，则负调控胰岛β细胞增殖。
Karnik SK 等研究者发现，当胰岛β细胞增殖处于静止状态时，P27 积累增多，







































细胞， 近，国内北京大学的邓宏魁等人采用 Tet-on 系统专一性地在小鼠胰岛
β细胞中高表达能够抑制胰岛β细胞分裂的 P21,在抑制了胰岛β细胞增殖后，


































第一章  前言 





。自从 1984 年 Hariotos 从大鼠胸腺分离到














的热点。Javier Freire 等人采用亲和层析、免疫印迹等方法，发现 ProTα不但
可以与 H2A，H2B，H3 和 H4 核内的组蛋白结合，参与染色体的解旋和重建，而且





ProTα还与结合有 CREB 蛋白的 CBP 相互作用，调节细胞转录环节
[76]
。ProTα作
为 Cmy 的下游调控基因，当 Cmy 表达升高时，ProTα水平明显上调。Rodriguez P









中。当核苷酸 dATP/ATP 存在时，细胞色素 C与凋亡蛋白酶活化因子-1(Apoptotic 
protease activating factor-1，Apaf-1)多聚化形成凋亡体(Apoptosome)后，
Apaf-1 通过 CARD 结构域招募多个 Caspase-9 分子进入复合物，而 Caspase-9 自
身又发生构象变化而水解，激活下游天冬氨酸特异性的半胱氨酸蛋白水解酶
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